首页>
中文期刊>
《国际肝胆胰疾病杂志(英文版)》
>Neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio is a predictive factor of pancreatic cancer patients with type 2 diabetes
Neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio is a predictive factor of pancreatic cancer patients with type 2 diabetes
To the Editor:Pancreatic cancer (PC) is one of the most deadly cancers due to the difficulty of its early diagnosis.Most patients have developed an unresectable PC when diagnosed [1].According to GLOBOCAN2018 estimates,PC ranked the 11th most common cancer in the world counting 458 918 new cases and causing 432 242 deaths(4.5%of all deaths caused by cancer) in 2018 [2].
展开▼